Header cover image

Mexican (IPC) Drug Retail Industry Analysis

UpdatedNov 24, 2024
DataAggregated Company Financials
Companies2
  • 7D-9.3%
  • 3M-23.2%
  • 1Y49.5%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has dropped 5.6%, driven by pullbacks from every company within the industry. In the past year, the industry has gained 72%. As for the next few years, earnings are expected to grow by 14% per annum.

Industry Valuation and Performance

Has the Mexican Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 24 Nov 2024Mex$78.6bMex$135.4bMex$5.1b32x15.5x0.6x
Tue, 22 Oct 2024Mex$94.2bMex$133.0bMex$5.1b34.1x18.3x0.7x
Thu, 19 Sep 2024Mex$98.4bMex$133.0bMex$5.1b34.4x19.1x0.7x
Sat, 17 Aug 2024Mex$104.0bMex$132.9bMex$5.2b31.8x20.1x0.8x
Mon, 15 Jul 2024Mex$100.9bMex$130.5bMex$5.0b31.2x20.2x0.8x
Wed, 12 Jun 2024Mex$89.8bMex$130.5bMex$5.0b29.4x18x0.7x
Fri, 10 May 2024Mex$85.1bMex$126.6bMex$4.7b26.9x18.1x0.7x
Sun, 07 Apr 2024Mex$75.5bMex$124.1bMex$4.2b25.8x17.8x0.6x
Tue, 05 Mar 2024Mex$67.3bMex$124.1bMex$4.2b24.6x15.9x0.5x
Thu, 01 Feb 2024Mex$59.0bMex$124.1bMex$4.2b23.7x13.9x0.5x
Sat, 30 Dec 2023Mex$56.2bMex$124.1bMex$4.2b23.2x13.3x0.5x
Mon, 27 Nov 2023Mex$53.1bMex$124.1bMex$4.2b22.6x12.5x0.4x
Wed, 25 Oct 2023Mex$53.6bMex$121.1bMex$3.9b22x13.8x0.4x
Fri, 22 Sep 2023Mex$53.9bMex$121.1bMex$3.9b21.3x13.9x0.4x
Sun, 20 Aug 2023Mex$53.9bMex$121.1bMex$3.9b20.2x13.9x0.4x
Tue, 18 Jul 2023Mex$50.5bMex$117.4bMex$3.5b27.2x14.5x0.4x
Thu, 15 Jun 2023Mex$51.4bMex$117.4bMex$3.5b20.2x14.8x0.4x
Sat, 13 May 2023Mex$50.5bMex$100.9bMex$3.4b15.1x15.1x0.5x
Mon, 10 Apr 2023Mex$46.6bMex$97.9bMex$3.2b14.7x14.7x0.5x
Wed, 08 Mar 2023Mex$39.7bMex$97.9bMex$3.2b12.5x12.5x0.4x
Fri, 03 Feb 2023Mex$33.3bMex$93.6bMex$3.0b11x11x0.4x
Sun, 01 Jan 2023Mex$31.5bMex$93.6bMex$3.0b11x10.4x0.3x
Tue, 29 Nov 2022Mex$31.6bMex$93.6bMex$3.0b10.4x10.4x0.3x
Thu, 27 Oct 2022Mex$30.9bMex$91.4bMex$2.9b10.7x10.7x0.3x
Sat, 24 Sep 2022Mex$31.5bMex$91.4bMex$2.9b10.9x10.9x0.3x
Mon, 22 Aug 2022Mex$32.6bMex$91.4bMex$2.9b11.3x11.3x0.4x
Wed, 20 Jul 2022Mex$29.4bMex$87.8bMex$2.7b10.7x10.7x0.3x
Fri, 17 Jun 2022Mex$30.7bMex$87.8bMex$2.7b11.2x11.2x0.3x
Sun, 15 May 2022Mex$33.9bMex$102.8bMex$2.8b36.8x12.1x0.3x
Tue, 12 Apr 2022Mex$32.1bMex$84.8bMex$2.6b12.3x12.3x0.4x
Thu, 10 Mar 2022Mex$31.9bMex$84.8bMex$2.6b12.2x12.2x0.4x
Sat, 05 Feb 2022Mex$32.0bMex$82.8bMex$2.5b12.8x12.8x0.4x
Mon, 03 Jan 2022Mex$33.1bMex$82.8bMex$2.5b13.2x13.2x0.4x
Wed, 01 Dec 2021Mex$31.9bMex$82.8bMex$2.5b12.7x12.7x0.4x
Price to Earnings Ratio

12.7x


Total Market Cap: Mex$31.9bTotal Earnings: Mex$2.5bTotal Revenue: Mex$82.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Mexican Drug Retail Industry Price to Earnings3Y Average 14x202220232024
Current Industry PE
    There are only 2 companies in the Mexican Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have grown 26% per year over the last three years.
  • Revenues for these companies have grown 18% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Mexican Drug Retail compare with similar industries?

MX Market-0.26%
Consumer Staples-1.94%
Food and Staples Retail-2.51%
Drug Retail-9.31%
Food Retail0.89%
Food Distributors0%
Big Box Super Stores-2.47%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.